Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.76
-0.03 (-0.36%)
Jun 8, 2026, 10:19 AM EDT - Market open
Immatics Market Cap
Immatics has a market cap or net worth of $1.31 billion as of June 8, 2026. Its market cap has increased by 110.19% in one year.
Market Cap
1.31B
Enterprise Value
807.23M
1-Year Change
110.19%
Ranking
Category
Stock Price
$9.76
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.31B, an increase of 658.33%. That is a compound annual growth rate of 31.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.31B | -6.74% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.37B |
| Maze Therapeutics | 1.34B |
| MoonLake Immunotherapeutics | 1.32B |
| Bicara Therapeutics | 1.31B |
| UroGen Pharma | 1.31B |
| Maravai LifeSciences Holdings | 1.30B |
| Damora Therapeutics | 1.29B |
| Savara | 1.29B |